Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSelective RET Inhibitor, BLU-667, Hits the Target in Patients with Lung or Thyroid Cancers.AuthorsStarr, PhoebeAbstractThe article evaluates the selective RET Inhibitor, BLU-667 for the treatment of patients with lung and thyroid cancers.SubjectsTHYROID cancer; LUNG cancerPublicationOncology Practice Management, 2018, Vol 8, Issue 9, p36ISSN2164-4403Publication typeProduct Review